Benzodiazepine Shortages: A Recurrent Challenge in Need of a Solution
Tài liệu tham khảo
Wick JY. The history of benzodiazepines. Consult Pharm. 2013;28(9):538–48.
Weintraub SJ. Diazepam in the treatment of moderate to severe alcohol withdrawal. CNS Drugs. 2017;31(2):87–95.
Wang GS, Baker K, Ng P, Janis GC, Leonard J, Mistry RD, et al. A randomized trial comparing physostigmine vs lorazepam for treatment of antimuscarinic (anticholinergic) toxidrome. Clin Toxicol. 2021;59(8):698–704.
Woolf AD, Erdman AR, Nelson LS, Caravati EM, Cobaugh DJ, Booze LL, et al. Tricyclic antidepressant poisoning: an evidence-based consensus guideline for out-of-hospital management. Clin Toxicol. 2007;45(3):203–33.
Boyer EW, Shannon M. The serotonin syndrome. N Engl J Med. 2005;352(11):1112–20.
Caroff S, Mann S, Keck P. Specific treatment of the neuroleptic malignant syndrome. Biol Psychiat. 1998;44(6):378–81.
Mazer-Amirshahi M, Hawley KL, Zocchi M, Fox E, Pines JM, Nelson LS. Drug shortages: implications for medical toxicology. Clin Toxicol. 2015;53(6):519–24.
Mazer-Amirshahi M, Fox ER, Nelson LS, Smith SW, Stolbach AI. ACMT position statement on prescription drug shortages. J Med Toxicol. 2020;16(3):349–51.
Farmer BM, Cole JB, Olives TD, Farrell NM, Rao R, Nelson LS, et al. ACMT position statement: medication administration and safety during the response to COVID-19 pandemic. J Med Toxicol. 2020;16(4):481–3.
Mazer-Amirshahi M, Fox ER, Farmer BM, Stolbach AI. ACMT position statement: medication shortages during coronavirus disease pandemic. J Med Toxicol. 2020;16(3):346–8.
Millikan D, Rice B, Silbergleit R. Emergency treatment of status epilepticus: current thinking. Emerg Med Clin North Am. 2009;27(1):101–13.
Soto P, Johnson-Arbor K, Fox ER, Mazer-Amirshahi M. 2022 ACMT Annual Scientific Meeting Abstracts – Virtual. Abstract 024: Drug Shortages Impacting Agents for Anticholinergic Delirium. J Med Toxicol. 2022;18(2):75–125.
Labus B, Sands L, Rowley P, Azzam I, Holmberg S, Perz J, et al. Acute Hepatitis C virus infections attributed to unsafe injection practices at an endoscopy clinic—Nevada, 2007. JAMA. 2008;299(23):2738.
Kaakeh R, Sweet BV, Reilly C, Bush C, DeLoach S, Higgins B, et al. Impact of drug shortages on U.S. health systems. Am J Health-Syst Pharmacy. 2011;68(19):1811–9.
Woodcock J, Wosinska M. Economic and technological drivers of generic sterile injectable drug shortages. Clin Pharmacol Ther. 2013;93(2): 170–176. https://doi.org/10.1038/clpt.2012.220
ACMT practice statement: antidote shortages: impact and response. American College of Medical Toxicology; 2012 [cited 2022 Sep 15]. Available from: https://www.acmt.net/_Library/Position_Drafts/AntidoteShortages111512.pdf. Accessed 20 Sept 2022.
Drug Shortages Infographic [Internet]. U.S. Food & Drug Administration. 2019. Available from: https://www.fda.gov/drugs/drug-shortages/drug-shortages-infographic. Accessed 15 Sept 2022.
Mazer-Amirshahi M, Fox ER. Saline shortages — many causes, no simple solution. N Engl J Med. 2018;378(16):1472–4.
Watson CJ, Whitledge JD, Siani AM, Burns MM. Pharmaceutical compounding: a history, regulatory overview, and systematic review of compounding errors. J Med Toxicol. 2021;17(2):197–217.
Fox ER, McLaughlin MM. ASHP guidelines on managing drug product shortages. Am J Health Syst Pharm. 2018;75(21):1742–50.
Mazer-Amirshahi M, Fox ER, Routsolias JC, Johnson-Arbor K, Mycyk MB. How Can We “Get the Lead Out” without chelators? J Med Toxicol. 2021;17(4):330–2.
Mazer-Amirshahi M, Stolbach A, Nelson LS. ACMT Position statement: addressing the rising cost of prescription antidotes. J Med Toxicol. 2018;14(2):168–71.
S.2595 - Drug Shortages Prevention and Quality Improvement Act. United States Congress. 2021. https://www.congress.gov/bill/117th-congress/senate-bill/2595 . Accessed 20 Sept 2022.
Phuong JM, Penm J, Chaar B, Oldfield LD, Moles R. The impacts of medication shortages on patient outcomes: a scoping review. PLoS One. 2019;14(5):e0215837.